BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
98.68
+2.62 (2.73%)
Sep 21, 2026, 2:59 PM EDT - Market open
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $24.79 billion as of September 21, 2026. Its market cap has increased by 7.17% in one year.
Market Cap
24.79B
Enterprise Value
9.77B
1-Year Change
7.17%
Ranking
Category
Stock Price
$98.68
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $24.79B, an increase of 727.68%. That is a compound annual growth rate of 35.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 24.79B | 8.29% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 41.59B |
| Revolution Medicines | 41.29B |
| Royalty Pharma | 33.91B |
| Alnylam Pharmaceuticals | 32.88B |
| Roivant Sciences | 28.21B |
| Insmed | 26.68B |
| Incyte | 25.47B |
| Genmab | 20.72B |